Howe & Rusling Inc Assembly Biosciences, Inc. Transaction History

Howe & Rusling Inc

  • $1.09 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019
SELL
$19.05 - $36.45 $381 - $729
-20 Closed
0 $0
Q3 2018

Nov 07, 2018
BUY
$34.41 - $44.23 $688 - $884
20 New
20 $1,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email